Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Ilmer

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Molecular Medicine Reports|April 2, 2016
Role of N-acetylgalactosaminyltransferase 6 in early tumorigenesis and formation of metastasisFriederike Liesche, Alexandra C Kölbl, Matthias Ilmer, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|May 1, 2020
Bernhard W Renz, Matthias Ilmer, Georg Beyer, et al.
Biomed Research International|July 11, 2015
Glycosyltransferases as Markers for Early TumorigenesisUlrich Andergassen, Friederike Liesche, Alexandra C Kölbl, et al.
International Journal of Nanomedicine|May 16, 2023
ROS Generative Black Phosphorus-Tamoxifen Nanosheets for Targeted Endocrine-Sonodynamic Synergistic Breast Cancer TherapyJing Wang, Weijian Chen, Wenxiang Du, et al.
Molecular Cancer Therapeutics|October 31, 2015
Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in HepatoblastomaMatthias Ilmer, Agnès Garnier, Jody Vykoukal, et al.
Oncology Letters|February 13, 2016
Truncated neurokinin-1 receptor is an ubiquitous antitumor target in hepatoblastoma, and its expression is independent of tumor biology and stageAgnès Garnier, Matthias Ilmer, Kristina Becker, et al.
Cells|January 21, 2022
Myeloid-Derived Suppressor Cells in Solid TumorsTianmiao Ma, Bernhard W Renz, Matthias Ilmer, et al.
Surgery|August 23, 2016
Anesthetic and operative considerations for laparoscopic liver resectionMichael E Egger, Vijaya Gottumukkala, Jonathan A Wilks, et al.
Cancer Journal (Sudbury, Mass.)|March 22, 2019
Repurposed Drugs in Pancreatic Ductal Adenocarcinoma: An UpdateMatthias Ilmer, C Benedikt Westphalen, Hanno Niess, et al.
International Journal of Oncology|May 23, 2015
Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cellsAgnès Garnier, Jody Vykoukal, Jochen Hubertus, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Molecular Medicine Reports|April 2, 2016
Role of N-acetylgalactosaminyltransferase 6 in early tumorigenesis and formation of metastasisFriederike Liesche, Alexandra C Kölbl, Matthias Ilmer, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|May 1, 2020
Bernhard W Renz, Matthias Ilmer, Georg Beyer, et al.
Biomed Research International|July 11, 2015
Glycosyltransferases as Markers for Early TumorigenesisUlrich Andergassen, Friederike Liesche, Alexandra C Kölbl, et al.
International Journal of Nanomedicine|May 16, 2023
ROS Generative Black Phosphorus-Tamoxifen Nanosheets for Targeted Endocrine-Sonodynamic Synergistic Breast Cancer TherapyJing Wang, Weijian Chen, Wenxiang Du, et al.
Molecular Cancer Therapeutics|October 31, 2015
Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in HepatoblastomaMatthias Ilmer, Agnès Garnier, Jody Vykoukal, et al.
Oncology Letters|February 13, 2016
Truncated neurokinin-1 receptor is an ubiquitous antitumor target in hepatoblastoma, and its expression is independent of tumor biology and stageAgnès Garnier, Matthias Ilmer, Kristina Becker, et al.
Cells|January 21, 2022
Myeloid-Derived Suppressor Cells in Solid TumorsTianmiao Ma, Bernhard W Renz, Matthias Ilmer, et al.
Surgery|August 23, 2016
Anesthetic and operative considerations for laparoscopic liver resectionMichael E Egger, Vijaya Gottumukkala, Jonathan A Wilks, et al.
Cancer Journal (Sudbury, Mass.)|March 22, 2019
Repurposed Drugs in Pancreatic Ductal Adenocarcinoma: An UpdateMatthias Ilmer, C Benedikt Westphalen, Hanno Niess, et al.
International Journal of Oncology|May 23, 2015
Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cellsAgnès Garnier, Jody Vykoukal, Jochen Hubertus, et al.
Pageof 7